Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 27393650)

  • 1. Calycosin induces apoptosis in colorectal cancer cells, through modulating the ERβ/MiR-95 and IGF-1R, PI3K/Akt signaling pathways.
    Zhao X; Li X; Ren Q; Tian J; Chen J
    Gene; 2016 Oct; 591(1):123-128. PubMed ID: 27393650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calycosin suppresses breast cancer cell growth via ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways.
    Chen J; Hou R; Zhang X; Ye Y; Wang Y; Tian J
    PLoS One; 2014; 9(3):e91245. PubMed ID: 24618835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calycosin induces apoptosis by the regulation of ERβ/miR-17 signaling pathway in human colorectal cancer cells.
    Chen J; Zhao X; Li X; Wu Y
    Food Funct; 2015 Sep; 6(9):3091-7. PubMed ID: 26215320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor beta-mediated proliferative inhibition and apoptosis in human breast cancer by calycosin and formononetin.
    Chen J; Zhao X; Ye Y; Wang Y; Tian J
    Cell Physiol Biochem; 2013; 32(6):1790-7. PubMed ID: 24355881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calycosin induces apoptosis in osteosarcoma cell line via ERβ‑mediated PI3K/Akt signaling pathways.
    Tian W; Wang ZW; Yuan BM; Bao YG
    Mol Med Rep; 2020 Jun; 21(6):2349-2356. PubMed ID: 32236598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calycosin suppresses colorectal cancer progression by targeting ERβ, upregulating PTEN, and inhibiting PI3K/Akt signal pathway.
    Zhu L; Liu S; Liao YF; Sheng YM; He JC; Cai ZX; Man Q; Wu YY
    Cell Biol Int; 2022 Sep; 46(9):1367-1377. PubMed ID: 35842774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Sun H; Yin M; Qian W; Yin H
    Med Sci Monit; 2018 Sep; 24():6178-6186. PubMed ID: 30182951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calycosin stimulates the osteogenic differentiation of rat calvarial osteoblasts by activating the IGF1R/PI3K/Akt signaling pathway.
    Fang Y; Xue Z; Zhao L; Yang X; Yang Y; Zhou X; Feng S; Chen K
    Cell Biol Int; 2019 Mar; 43(3):323-332. PubMed ID: 30632644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
    Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calycosin and genistein induce apoptosis by inactivation of HOTAIR/p-Akt signaling pathway in human breast cancer MCF-7 cells.
    Chen J; Lin C; Yong W; Ye Y; Huang Z
    Cell Physiol Biochem; 2015; 35(2):722-8. PubMed ID: 25613518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-I stimulates ERβ and aromatase expression via IGF1R/PI3K/AKT-mediated transcriptional activation in endometriosis.
    Zhou Y; Zeng C; Li X; Wu PL; Yin L; Yu XL; Zhou YF; Xue Q
    J Mol Med (Berl); 2016 Aug; 94(8):887-97. PubMed ID: 26899323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formononetin induces cell cycle arrest of human breast cancer cells via IGF1/PI3K/Akt pathways in vitro and in vivo.
    Chen J; Zeng J; Xin M; Huang W; Chen X
    Horm Metab Res; 2011 Sep; 43(10):681-6. PubMed ID: 21932171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways.
    Wei ZJ; Tao ML; Zhang W; Han GD; Zhu ZC; Miao ZG; Li JY; Qiao ZB
    Int J Clin Exp Pathol; 2015; 8(5):4481-91. PubMed ID: 26191138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
    Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
    Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumol inhibits colorectal cancer proliferation by targeting miR-21 and modulated PTEN/PI3K/Akt pathways.
    Liu H; Wang J; Tao Y; Li X; Qin J; Bai Z; Chi B; Yan W; Chen X
    Life Sci; 2019 Mar; 221():354-361. PubMed ID: 30811964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
    Wang Y; Tang Q; Li M; Jiang S; Wang X
    Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-503 regulates hypoxia-induced cardiomyocytes apoptosis through PI3K/Akt pathway by targeting IGF-1R.
    Zhu W; Lei J; Bai X; Wang R; Ye Y; Bao J
    Biochem Biophys Res Commun; 2018 Dec; 506(4):1026-1031. PubMed ID: 30404731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interruption of mitochondrial complex IV activity and cytochrome c expression activated O₂·⁻-mediated cell survival in silibinin-treated human melanoma A375-S2 cells via IGF-1R-PI3K-Akt and IGF-1R-PLC γ-PKC pathways.
    Jiang YY; Huang H; Wang HJ; Wu D; Yang R; Tashiro S; Onodera S; Ikejima T
    Eur J Pharmacol; 2011 Oct; 668(1-2):78-87. PubMed ID: 21703257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.